Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding FR:EMSR?
Track your performance easily
FR:EMSR Price & Analysis
EMSR ETF Chart & Stats
Day’s Range― - ―
52-Week Range$120.41 - $140.80
Previous Close$137.76
VolumeN/A
Average Volume (3M)674.00
AUM18.63K
NAV136.92
Expense Ratio0.30%
Holdings Count61
Beta0.60
Inception DateJul 21, 2016
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares Outstanding1,627,737
Standard Deviation0.05
10 Day Avg. Volume565
30 Day Avg. Volume674
Alpha-0.00267
MSCI Emerging SRI S-Series PAB 5% Capped UCITS ETF Capitalisation (EMSR) Fund Flow Chart
MSCI Emerging SRI S-Series PAB 5% Capped UCITS ETF Capitalisation (EMSR) 1 year Net Flows: -$150M
EMSR ETF News
EMSR ETF FAQ
What was FR:EMSR’s price range in the past 12 months?
FR:EMSR lowest ETF price was $120.41 and its highest was $140.80 in the past 12 months.
What is the AUM of FR:EMSR?
As of May 10, 2024 The AUM of FR:EMSR is 18.63K.
Is FR:EMSR overvalued?
According to Wall Street analysts FR:EMSR’s price is currently Undervalued.
Does FR:EMSR pay dividends?
FR:EMSR does not currently pay dividends.
How many shares outstanding does FR:EMSR have?
FR:EMSR has 1,627,737 shares outstanding.
Which hedge fund is a major shareholder of FR:EMSR?
Currently, no hedge funds are holding shares in FR:EMSR
Top 10 Holdings
U.S. Dollar
11.57%
BNP Paribas SA (UK)
8.83%
AXA SA (UK)
6.53%
Lanxess (OTC)
6.27%
Compagnie de Saint Gobain
5.69%
Credit Agricole SA (UK)
4.96%
Societe Generale (UK)
3.76%
Schneider Electric SE (UK)
3.56%
BNP Paribas InstiCash SICAV - BNP Paribas InstiCash USD 1D LVNAV I Capitalisation
3.50%
Knorr-Bremse AG
3.21%
Total57.87%
ETF Description
MSCI Emerging SRI S-Series PAB 5% Capped UCITS ETF Capitalisation
The Fund seeks to replicate (with a maximum tracking error of 1%) the performance of the MSCI Emerging SRI S-Series PAB 5% Capped (NTR) index (Bloomberg: M7CXESC index) (the Index) by investing in a substitute basket, composed of, inter alia, shares of companies, debt securities or cash (synthetic replication).